Purdue-discovered 'fluorescent markers' to illuminate cancer, improve outcomes, receives FDA fast track as Phase 3 clinical trials begin
On Target Laboratories Inc., a privately held biotechnology company developing the use of Purdue University-discovered fluorescent markers to target and illuminate cancer during su…
